These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 12651630)

  • 41. Complement C5a anaphylatoxin fragment causes apoptosis in TGW neuroblastoma cells.
    Farkas I; Baranyi L; Liposits ZS; Yamamoto T; Okada H
    Neuroscience; 1998 Oct; 86(3):903-11. PubMed ID: 9692726
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Residues 21-30 within the extracellular N-terminal region of the C5a receptor represent a binding domain for the C5a anaphylatoxin.
    Chen Z; Zhang X; Gonnella NC; Pellas TC; Boyar WC; Ni F
    J Biol Chem; 1998 Apr; 273(17):10411-9. PubMed ID: 9553099
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Independent regulation of human neutrophil chemotactic receptors after activation.
    Bender JG; Van Epps DE; Chenoweth DE
    J Immunol; 1987 Nov; 139(9):3028-33. PubMed ID: 2822801
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Selection of a C5a receptor antagonist from phage libraries attenuating the inflammatory response in immune complex disease and ischemia/reperfusion injury.
    Heller T; Hennecke M; Baumann U; Gessner JE; zu Vilsendorf AM; Baensch M; Boulay F; Kola A; Klos A; Bautsch W; Köhl J
    J Immunol; 1999 Jul; 163(2):985-94. PubMed ID: 10395696
    [TBL] [Abstract][Full Text] [Related]  

  • 45. C3a and C5a are chemotaxins for human mast cells and act through distinct receptors via a pertussis toxin-sensitive signal transduction pathway.
    Nilsson G; Johnell M; Hammer CH; Tiffany HL; Nilsson K; Metcalfe DD; Siegbahn A; Murphy PM
    J Immunol; 1996 Aug; 157(4):1693-8. PubMed ID: 8759757
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Requirements for C5a receptor-mediated IL-4 and IL-13 production and leukotriene C4 generation in human basophils.
    Eglite S; Plüss K; Dahinden CA
    J Immunol; 2000 Aug; 165(4):2183-9. PubMed ID: 10925305
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Biologically active conformer of the effector region of human C5a and modulatory effects of N-terminal receptor binding determinants on activity.
    Finch AM; Vogen SM; Sherman SA; Kirnarsky L; Taylor SM; Sanderson SD
    J Med Chem; 1997 Mar; 40(6):877-84. PubMed ID: 9083476
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Structure-function studies in a series of carboxyl-terminal octapeptide analogues of anaphylatoxin C5a.
    Kawai M; Quincy DA; Lane B; Mollison KW; Or YS; Luly JR; Carter GW
    J Med Chem; 1992 Jan; 35(2):220-3. PubMed ID: 1732540
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dual functions of the C5a receptor as a connector for the K562 erythroblast-like cell-THP-1 macrophage-like cell island and as a sensor for the differentiation of the K562 erythroblast-like cell during haemin-induced erythropoiesis.
    Nishiura H; Zhao R; Yamamoto T
    Clin Dev Immunol; 2012; 2012():187080. PubMed ID: 23346183
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Acquired immune response as a consequence of the macrophage-dependent apoptotic cell clearance and role of the monocyte chemotactic S19 ribosomal protein dimer in this connection.
    Shrestha A; Horino K; Nishiura H; Yamamoto T
    Lab Invest; 1999 Dec; 79(12):1629-42. PubMed ID: 10616212
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mutation of the key residue for extraribosomal function of ribosomal protein S19 cause increased grooming behaviors in mice.
    Chen J; Kaitsuka T; Fujino R; Araki K; Tomizawa K; Yamamoto T
    Neurosci Lett; 2016 Aug; 629():221-226. PubMed ID: 27424793
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Involvement of regional neutrophil apoptosis promotion by ribosomal protein S19 oligomers in resolution of experimental acute inflammation.
    Nishiura H; Zhao R; Chen J; Taniguchi K; Yamamoto T
    Pathol Int; 2013 Dec; 63(12):581-90. PubMed ID: 24422954
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Anti-C5a receptor antibodies. Characterization of neutralizing antibodies specific for a peptide, C5aR-(9-29), derived from the predicted amino-terminal sequence of the human C5a receptor.
    Morgan EL; Ember JA; Sanderson SD; Scholz W; Buchner R; Ye RD; Hugli TE
    J Immunol; 1993 Jul; 151(1):377-88. PubMed ID: 8326131
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Direct binding of a fragment of the Wiskott-Aldrich syndrome protein to the C-terminal end of the anaphylatoxin C5a receptor.
    Tardif M; Brouchon L; Rabiet MJ; Boulay F
    Biochem J; 2003 Jun; 372(Pt 2):453-63. PubMed ID: 12600272
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Response-selective C5a agonists: differential effects on neutropenia and hypotension in the rat.
    Short AJ; Paczkowski NJ; Vogen SM; Sanderson SD; Taylor SM
    Br J Pharmacol; 1999 Oct; 128(3):511-4. PubMed ID: 10516626
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dynamics of a chemoattractant receptor in living neutrophils during chemotaxis.
    Servant G; Weiner OD; Neptune ER; Sedat JW; Bourne HR
    Mol Biol Cell; 1999 Apr; 10(4):1163-78. PubMed ID: 10198064
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A neuronal C5a receptor and an associated apoptotic signal transduction pathway.
    Farkas I; Baranyi L; Takahashi M; Fukuda A; Liposits Z; Yamamoto T; Okada H
    J Physiol; 1998 Mar; 507 ( Pt 3)(Pt 3):679-87. PubMed ID: 9508829
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Co-expression of chemotactic ligand receptors on human peripheral blood monocytes.
    Ohura K; Katona IM; Wahl LM; Chenoweth DE; Wahl SM
    J Immunol; 1987 Apr; 138(8):2633-9. PubMed ID: 2435802
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Relationship of C5a receptor modulation to the functional responsiveness of human polymorphonuclear leukocytes to C5a.
    Van Epps DE; Simpson SJ; Johnson R
    J Immunol; 1993 Jan; 150(1):246-52. PubMed ID: 8417126
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Agonist-dependent phosphorylation of N-formylpeptide and activation peptide from the fifth component of C (C5a) chemoattractant receptors in differentiated HL60 cells.
    Tardif M; Mery L; Brouchon L; Boulay F
    J Immunol; 1993 Apr; 150(8 Pt 1):3534-45. PubMed ID: 8468487
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.